PAA 7.89% 20.5¢ pharmaust limited

Pharmaust Phase II K9 Trial, page-407

  1. 474 Posts.
    lightbulb Created with Sketch. 286
    Agree, I'm looking forward to a December update that can be celebrated by all shareholders as human trial preparation is announced based on the success of phase 2 K9 trials.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.